Validation by the European Commission of Elogen's participation in the Hydrogen IPCEI

2022-07-18

Elogen announces that its “gigafactory” and R&D strengthening project  has been selected by the European Commission as part of the Hydrogen IPCEI (Important Project of Common European Interest).

On July 15, 2022, the European Commission authorized the 15 Member States concerned by the “Hy2Tech” IPCEI to provide public funding of up to 5.4 billion euros .

Elogen is one of the 41 projects selected as part of the Hy2Tech IPCEI, in the “Hydrogen production technology” category.
Elogen's project consists, on the one hand, in increasing the intensity of its R&D to develop innovative stacks of electrolysers  with proton exchange membranes, and, on the other hand, in building, in Vendôme (Loir-et -Cher), a factory allowing the mass production of these stacks.

As a reminder, the Elogen gigafactory will start its production in 2025 and will have a production capacity of 1 GW.
Information on the amount of aid granted to each of the IPCEI participants will be available in the non-confidential version  of the European Commission's decision.

***
    
About Elogen
    
Elogen, a technological expert at the service of green hydrogen, develops cutting-edge technologies to design and produce PEM (Proton Exchange Membrane) electrolysers to meet new uses of hydrogen in mobility, industry and energy storage. Elogen, a company of the GTT group, relies on a powerful R&D and a rigorous manufacturing process to provide its customers with competitive, reliable systems tailored to their needs. The technological solutions developed by Elogen, particularly suitable for renewable energies, demonstrate high efficiency and performance. 

More information on elogenh2.com
Contact: contact@elogenh2.com 

Download in .pdf

[1]See the press release published on March 8, 2022.

[2] See the press release published by the European Commission on July 15, 2022.
[3]An electrolyser consists of several stacks; stacks are the reactors in which the electrolysis takes place.

[4] Redacted of confidential business secrets.